Interstitial lung disease and connective tissue diseases

Guler, Sabina; Geiser, Thomas (2016). Interstitial lung disease and connective tissue diseases. Therapeutische Umschau, 73(1), pp. 37-42. Huber 10.1024/0040-5930/a000753

Full text not available from this repository. (Request a copy)

Lung involvement in rheumatologic diseases has a broad spectrum of clinical and radiological presentations, from acute inflammatory to chronic, fibrosing predominance. For prognostic and therapeutic considerations a detailled work-up 'and optimally multidisciplinary evalution is needed, also to rule out other reasons for pulmonary deterioration such as infection (under immunosuppressive treatment) or pulmonary hypertension. For treatment guidance, several aspects need to be taken into consideration, such as disease severity, disease activity, clinical and radiological presentation, prognostic markers and comorbidities. Immunosuppressive treatment differs based on the type of rheumatologic diagnosis, although evidence for optimal therapy is rare in ILD associated with rheumatologic diseases.

Item Type:

Journal Article (Further Contribution)

Division/Institute:

04 Faculty of Medicine > Department of Gastro-intestinal, Liver and Lung Disorders (DMLL) > Clinic of Pneumology

UniBE Contributor:

Guler, Sabina and Geiser, Thomas

Subjects:

600 Technology > 610 Medicine & health

ISSN:

0040-5930

Publisher:

Huber

Language:

German

Submitter:

Rahel Holderegger

Date Deposited:

22 Mar 2017 13:24

Last Modified:

30 Sep 2017 15:58

Publisher DOI:

10.1024/0040-5930/a000753

PubMed ID:

26884219

URI:

https://boris.unibe.ch/id/eprint/93080

Actions (login required)

Edit item Edit item
Provide Feedback